Depressive disorders are common conditions that place a large burden of illness on
patients, employers, payers, and society. Although efficacious interventions exist to treat …

This study evaluated the relative clinical-and cost-effectiveness of venlafaxine (Efectin®,
Wyeth Pharmaceuticals, Austria) extended release (ER), venlafaxine instant release (IR) …

Venlafaxin ist ein selektives Antidepressivum, indem es-wie selektiv-serotonerge
Antidepressiva (SSRI)-frei von den anticholinergen, antihistaminergen, antiadrenergen und …

Objective: This study examines the adherence of Dutch pharmacoeconomic studies to the
national guidelines of conducting a pharmacoeconomic evaluation. Methods: Dutch …

Over the past decade, psychiatric disorders have increasingly been regarded as serious
public health concerns, with debilitating symptoms as well as high social and economic …

Objective. To compare the efficiency of the treatment of major depressive disorder (MDD)
and generalized anxiety disorder (GAD) with venlafaxine in comparison with tricyclic …

73 снижения или утраты трудоспособности пациента, а также уменьшения занятости
членов его семьи, затраты на его социальное обеспечение и пр.). И, наконец,« …

Depression is one of the most debilitating disorders in the world. The currently available
medications typically have a 2-4 week delay in their therapeutic effects and are ineffective …

Objetivo: Analizar la utilización y consumo de venlafaxina XR en los pacientes psiquiátricos
ambulatorios atendidos en el Servicio de Salud Mental del HNERM entre enero 2014 y …